Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 21, 2019; 25(35): 5388-5402
Published online Sep 21, 2019. doi: 10.3748/wjg.v25.i35.5388
Published online Sep 21, 2019. doi: 10.3748/wjg.v25.i35.5388
No. | Sex, age (yr) | HIV status | Presentation | ANA titer | ASMA titer | Treatment | Outcome | |||
HIV Duration | ART duration | Viral load | CD4 | |||||||
1[21] | NA | NA | NA | < 48 | 1011 | NA | 1:640 | 1:40 | P+ Z | Remission |
2[21] | NA | NA | NA | < 48 | 456 | NA | Neg | 1:20 | P+ Z | Remission |
3[21] | NA | NA | NA | < 48 | 783 | NA | 1:40 | 1:320 | P+ Z | Remission |
4[21] | NA | NA | NA | < 48 | 688 | Acute liver failure | 1:640 | 1:160 | LT | Relapse at 4 yr after LT |
5[21] | NA | NA | NA | < 48 | 653 | n/a | 1:1280 | 1:20 | P+ Z | Remission |
6[22] | M, 54 | NA | 3 yr | 5104 | 357 | ↑ ALT* | 1:40 | 1:640 | P+ Z | Remission |
7[22] | F, 55 | NA | NA | < 50 | 174 | ↑ ALT | Neg | 1:40 | P+ Z | Relapse |
8[22] | F, 49 | NA | NA | 69318 | 286 | ↑ ALT | Neg | Neg | P+ Z | Died |
9[22] | F, 56 | NA | NA | 232734 | 331 | ↑ ALT | 1:40 | 1:20 | P | Died |
10[23] | M, 21 | Newly diagnosed | 0 | 7900 | 753 | Jaundice | Neg | Neg | P | Relapse |
11[23] | F, 59 | n/a | 7 mo | - | 504 | ↑ ALT | Pos | Pos | P+ Z | Remission |
12[24] | M, 26 | 3 yr | 1 yr | - | NA | Jaundice | 1:160 | Neg | P+ Z | Relapse |
13[25] | M, 40 | 8 yr | 8 yr | ND | 832 | ↑ ALT | Neg | 1:60 | P+ Z | Relapse |
14[25] | F, 44 | 20 yr | 7 yr | ND | 823 | Acute hepatitis* | 1:640 | 1:180 | P | Remission |
15[26] | M, 52 | 7 yr | 7 | ND | 641 | ↑ ALT | 1:2560 | NA | P | Remission |
16[27] | F, 44 | 9 mo | 9 mo | ND | 526 | ↑ ALT | 1:160 | 1:160 | P+ Z | Minor flare during taper steroid |
17[28] | M, 29 | Newly diagnosed | 0 | 7122 | 259 | ↑ ALT | Neg | Neg | none | Resolved spontaneously |
18[28] | F, 45 | 2 yr | 7 mo | ND | 297 | ↑ ALT | 1:640 | Neg | P+Z | Remission |
19[28] | F, 65 | 10 yr | n/a | ND | 922 | ↑ ALT | 1:160 | 1:320 | P+Z → MMF | Flare |
20[29] | M, 38 | 2 yr after AIH diagnosed | 0 | 81000 | 216 | ↑ ALT | 1:320 | 1:40 | ART | ALT improved after ART initiaion |
21[30] | F, - | 15 yr | 12 yr | ND | 634 | Acute hepatitis | 1:20000 | Neg | P | Remission |
22[31] | F, 48 | 20 yr | NA | ND | > 250 | Acute hepatitis | 1:80 | 1:300 | P | Died |
23[32] | F, 23 | NA | 8 mo | ND | 523 | ↑ Jaundice and ALT* | Pos | Neg | P ± Z | Remission |
24[32] | F, 31 | NA | 7 mo | < 40 | 277 | Pos | Neg | |||
25[32] | F, 42 | NA | 10 mo | - | 593 | Pos | Pos | |||
26[32] | F, 45 | NA | 6 mo | < 40 | 253 | Neg | Pos | |||
27[32] | F, 35 | NA | 41 mo | ND | 339 | Neg | Pos | |||
28[32] | M, 39 | NA | 77 mo | ND | 416 | Neg | Pos | |||
29[32] | F, 39 | NA | 4 mo | ND | 357 | Neg | Pos | |||
30[32] | F, 43 | NA | 4 mo | ND | 876 | Pos | Neg | |||
31[32] | F, 36 | NA | 17 mo | ND | 693 | Neg | Pos | |||
32[33] | F, 42 | 20 yr | NA | ND | 232 | Acute hepatitis | 1:1280 | Neg | P | Remission |
33[34] | F, 51 | NA | 11 mo | 94 | 417 | Acute liver failure | 1:256 | 1:80 | P | Died |
34[35] | F, 38 | 13 yr | NA | 6392 | 436 | NA | 1:400 | Pos | B | Remission |
35[36] | M, 38 | 2 yr | 0 | 8072 | 762 | Acute hepatitis | 1:640 | 1:160 | P+Z | Remission |
36[37] | F, 70 | 32 yr | 24 yr | < 50 | 938 | Decompensated cirrhosis* | 1:640 | NA | P | Remission |
37[38] | M, 43 | 13 yr | 2 yr | ND | 900 | ↑ ALT | 1:160 | NA | P | Remission |
38[39] | F, 43 | 4 yr | 18 mo | ND | 425 | Acute hepatitis | 1:8000 | Neg | P+Z | Flare during tapering steroid |
- Citation: Chaiteerakij R, Sanpawat A, Avihingsanon A, Treeprasertsuk S. Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature. World J Gastroenterol 2019; 25(35): 5388-5402
- URL: https://www.wjgnet.com/1007-9327/full/v25/i35/5388.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i35.5388